Imunon, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
IMNN on Nasdaq
Industry
Pharmaceutical Preparations
Location
997 Lenox Drive, Suite 100, Lawrenceville, NJ

There are no Buy or Sell transactions made by insiders since 11/21/2024

Imunon, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Michael Tardugno Executive Chairman of Board, Director $364K Aug 4, 2025
Constantine J. Kardaras Chief Accounting Officer $57.4K Jun 13, 2022
Corinne Le Goff President and CEO, Director $51.9K Mar 17, 2023
Frederick J. Fritz Director $36.3K Aug 4, 2025
Donald P. Braun Director $34.5K Aug 4, 2025
James E. Dentzer Director $30.5K Aug 4, 2025
Christine Pellizzari Director $20.7K Aug 4, 2025
Sebastien Hazard Chief Medical Officer $19.6K Dec 7, 2023
Kimberly Bragg Cfo $16.3K Aug 4, 2025
Robert W. Hooper Director $12.3K Jun 13, 2022
Stacy Lindborg President and CEO, Director $1.91K Sep 6, 2025
Timothy J. Tumminello Controller Jun 13, 2022
Jeffrey Wayne Church Cfo Mar 15, 2024
Susan Eylward General Counsel and Corp Sec Aug 4, 2025
Douglas V. Faller Chief Medical Officer Feb 18, 2025
Khursheed Anwer Chief Scientific Officer Aug 4, 2025
David Gaiero Chief Financial Officer Jun 1, 2024
Pok Yu Augustine Chow Director Mar 17, 2023

Recent Insider Transactions by Companies or Individuals for Imunon, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.